Smith & Nephew, Inc.: Ulcer trials

The registry lists 31 Ulcer studies with Smith & Nephew, Inc. as lead sponsor. 0 are open to participants now and 19 have results posted.

Phase 2 4Phase 3 4Phase 4 15No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic WoundsTerminatedNCT05234632Results posted
• Evaluation Of An Advanced Borderless DressingCompletedNCT03146845Not applicableResults posted
• Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure UlcersTerminatedNCT02718625Phase 4Results posted
• Use of Santyl in Diabetic Foot UlcersCompletedNCT02581488Phase 4Results posted
• Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)CompletedNCT02470806Not applicableResults posted
• A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg UlcersTerminatedNCT02154087Phase 2Results posted
• Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg UlcersTerminatedNCT01853384Phase 3Results posted
• Study of Oasis Ultra in Diabetic Foot UlcersCompletedNCT01835379Phase 4Results posted
• Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2CompletedNCT01737762Phase 3Results posted
• Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg UlcersCompletedNCT01656889Phase 3Results posted
• Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord InjuryTerminatedNCT01433159Phase 2Results posted
• Using Santyl on Diabetic Foot UlcersCompletedNCT01408277Phase 4Results posted
• Wound Edge Changes Following Treatment With SantylCompletedNCT01197898Phase 4Results posted
• Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot UlcersCompletedNCT01143727Phase 4Results posted
• A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot UlcersCompletedNCT01143714Phase 4Results posted
• Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness WoundsCompletedNCT00971048Not applicableResults posted
• Safety Follow-Up to HP 802-247-09-015CompletedNCT00900029Results posted
• Dose Finding Study of HP802-247 in Venous Leg UlcersCompletedNCT00852995Phase 2Results posted
• OASIS Wound Matrix (Oasis) Mechanism of ActionCompletedNCT00570141Phase 4Results posted
• Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg UlcersCompletedNCT03629236Not applicable
• TruSkin®: Study for Treatment of Chronic Venous Leg UlcersTerminatedNCT02936128Phase 4
• TruSkin®: Study for the Treatment of Chronic Diabetic Foot UlcersTerminatedNCT02936115Phase 4
• ACTICOAT™ for the Treatment of Burns and Chronic WoundsCompletedNCT02852148Not applicable
• Use of Santyl Within an Accountable Care OrganizationWithdrawnNCT02716519Phase 4
• GrafixPRIME® for the Treatment of Chronic Diabetic Foot UlcersCompletedNCT02675855Phase 4
• Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot UlcersTerminatedNCT02571738Phase 3
• Santyl Applications to Diabetic Foot UlcersCompletedNCT02111291Phase 4
• Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg UlcerStatus unknownNCT01658618
• Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot UlcersCompletedNCT01596920Phase 4
• HP011-101, HP828-101, and Standard Care for Pressure UlcersWithdrawnNCT01273428Phase 2
• Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb UlcersCompletedNCT00521027Phase 4